Fibrocor Therapeutics Inc. ('Fibrocor' or 'the Company'), a biotech company developing first-in-class therapies for kidney diseases, with a strong focus on Alport Syndrome, today announces the ...

From microglia reprogramming to immune cell-based diagnostics, 2025 was a big year for breakthroughs in cell biology.

A new article reflects on how two generations of scientists reshaped thinking on aging, linking hormonal regulation in the brain to molecular growth pathways. Mikhail Blagosklonny spent his career ...

Combination Potential: When combined with an anti-PD-1 antibody, Compound 10 significantly inhibited tumor growth, ...

Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 million contract from the Advanced Research Projects Agency for Health (ARPA-H) ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Cell death triggered by GPX4 loss was slowed in cell cultures and in mouse model using compounds that specifically inhibit ferroptosis.

A major study shows complex cells evolved gradually in an oxygen-poor world, challenging long-held assumptions about life’s ...

A research group has demonstrated that overexpression of Cdc10-dependent transcript 1 (CDT1), a key regulator of DNA ...

Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...

Detectives often find important clues by digging through rubbish. That approach paid off tremendously for systems biologist ...

The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.